Every New York stock exchange trading day I'm posting a daily dividend stock or fund review. I'll share the three chief qualities of just one equity or fund that could be selected for a dividend stock portfolio I've named the Safari to Sweet Success.

This week my Safari portfolio seeks a company in the healthcare sector. 

That sector includes ten industries all related to testing, diagnosing and treating what ails us. The healthcare industries are: biotechnology; diagnostics & research; drug manufacturers - major; drug manufacturers - specialty & generic; healthcare plans; long-term care facilities; medical care; medical devices, medical distribution; medical supplies.

Today I'm reviewing a medical device company, Sonova Holding AG. Its trading ticker symbol is SONVY. 

Sonova Holding AG develops and sells technologically advanced hearing systems for adults and children.

The company operates in the Americas, Europe, the Middle East, Africa, and Asia, offering its products through a proprietary sales and distribution network, of about 50 wholesale companies and 100 independent distributors, and the AudioNova retail network of approximately 3,300 locations in 12 markets. 

The company was formerly known as Phonak Holding AG and changed its name to Sonova in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

I use three primary keys to gauge dividend equities or funds like Sonova Holding AG (SONVY): 

(1) Price

(2) Dividends

(3) Returns

SONVY Price

Sonova Holding's price at yesterday's market close was $31.01 per share.A year ago its price was $25.88. Thus, it gained$5.13 per share in the past year.  

If SONVY does as well this coming year its value will increase from $31.01 to $36.14, or about 16.6%. 

SNOVY Dividends

Sonova Holding's most recent annual dividend was $0.47 declared May 13th and paid July 5th, 2017.  

The annual dividend for 2018 is estimated at the same$0.47 payable in July.

The yield from that $0.47 annual dividend was over 1.5% at yesterday's $31.01 price.

Any Gains For SONVY?

Adding the $0.47 dividend to the hypothetical $5.13 estimated year over year price gain shows a potential $5.60 gross gain for the coming year.  

Subtracting the cost to trade Sonova Holding's (SONVY) shares,$1,000.00 investment at yesterday's $31.01 price bought 32 shares. 

Those 32 shares cost us broker fees of $5 at purchase and another $5 at sale for a per share cost of about $0.31 per share

Subtract that $0.31 brokerage cost from the estimated $5.60 gross gain leaves a net gain to 2019 of $5.29 X 32 shares = $169.28 or a 17% net gain on a $992.32 investment.

Therefore, Sonova Holding AG(whose ticker symbol is SONVY ), now shows a possible 17% gain by my simple year over year calculation with a 1.5% dividend included. (Which is below the 3.5% standard dividend for my Safari portfolio.) 

No analysts cover this stock but the ten-year price chart I saw showed a peak price gain to $36 in November 2017.

These forward-looking numbers are conjecture based on past year performance. The actual results remain to be seen.They could turn out to be far lower. More study is required for you to determine if Sonova Holding AG (SONVY) is worth your time and money.